Attainment of a Stringent Complete Response in Multiple Myeloma With Thalidomide Monotherapy

Internal Medicine - Japan
doi 10.2169/internalmedicine.51.7860
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Successful Treatment of Extramedullary Tumors With Low-Dose Thalidomide in Patients With Multiple Myeloma

Internal Medicine
Internal MedicineMedicine
2010English

Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Effect of Thalidomide on Stem Cell Collection and Engraftment in Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2003English

Pulmonary Embolism Developing During Thalidomide Therapy for Multiple Myeloma in a Hemodialysis Patient

Nihon Toseki Igakkai Zasshi
2011English

Gene Expression Profile Alone Is Inadequate in Predicting Complete Response in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Thalidomide and Dexamethasone: A New Standard of Care for Initial Therapy in Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Long-Term Thalidomide Therapy Resulted in Lack of Mdr1 Gene Expression in a Patient With Primary Resistant Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology
Hematology
2010English

Carfilzomib Monotherapy in Japanese Patients With Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

Cancer Science
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy